Soleno Therapeutics, Inc.SLNONASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
117.86
↑ 6764% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
1.72
Historical baseline
PeriodValueYoY Change
2025117.86+1247.6%
2024-10.27+39.7%
2023-17.03-392.9%
2022-3.45+34.7%
2021-5.29+78.4%
2020-24.53-50.4%
2019-16.31-21.3%
2018-13.45-160.8%
2017-5.16+0.9%
2016-5.21-